F. Nosten and N. White, Artemisinin-based combination treatment of falciparum malaria, Am J Trop Med Hyg, vol.77, pp.181-192, 2007.

P. Brasseur, P. Agnamey, O. Gaye, M. Vaillant, W. Taylor et al., Efficacy and safety of artesunate plus amodiaquine in routine use for the treatment of uncomplicated malaria in Casamance, southern Senegal, Malaria Journal, vol.6, issue.1
DOI : 10.1186/1475-2875-6-150

M. Makanga, Q. Bassat, C. Falade, Z. Premji, S. Krudsood et al., Efficacy and Safety of Artemether-Lumefantrine in the Treatment of Acute, Uncomplicated Plasmodium falciparum Malaria: A Pooled Analysis, American Journal of Tropical Medicine and Hygiene, vol.85, issue.5, pp.793-804, 2011.
DOI : 10.4269/ajtmh.2011.11-0069

S. Sirima, A. Tiono, A. Gansané, A. Diarra, A. Ouédraogo et al., The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum, Malaria Journal, vol.8, issue.1
DOI : 10.1186/1475-2875-8-48

C. Hatton, T. Peto, C. Bunch, G. Pasvol, S. Russell et al., FREQUENCY OF SEVERE NEUTROPENIA ASSOCIATED WITH AMODIAQUINE PROPHYLAXIS AGAINST MALARIA, The Lancet, vol.327, issue.8478, pp.411-414, 1986.
DOI : 10.1016/S0140-6736(86)92371-8

L. Markham, E. Giostra, A. Hadengue, M. Rossier, M. Rebsamen et al., Emergency liver transplantation in amodiaquine-induced fulminant hepatitis, Am J Trop Med Hyg, vol.77, pp.14-15, 2007.

K. Neftel, W. Woodtly, M. Schmid, P. Frick, and J. Fehr, Amodiaquine induced agranulocytosis and liver damage., BMJ, vol.292, issue.6522, pp.721-723, 1986.
DOI : 10.1136/bmj.292.6522.721
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1339778/pdf

A. Akpalu, . Jr, P. Nyame, and A. Dodoo, Amodiaquine-induced dystonic reactions: case reports and implications for policy change in Ghana

D. Bethell, Y. Se, C. Lon, D. Socheat, D. Saunders et al., Malaria, Clinical Infectious Diseases, vol.51, issue.12, pp.105-114, 2010.
DOI : 10.1086/657402

J. Ndiaye, M. Randrianarivelojosia, I. Sagara, P. Brasseur, I. Ndiaye et al., Randomized, multicentre assessment of the efficacy and safety of ASAQ ??? a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria, Malaria Journal, vol.8, issue.1, p.125, 2009.
DOI : 10.1186/1475-2875-8-125

B. Schramm, P. Valeh, E. Baudin, C. Mazinda, R. Smith et al., Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-inferiority trial, Malaria Journal, vol.12, issue.1, p.251, 2013.
DOI : 10.1016/S0035-9203(02)90348-2
URL : https://hal.archives-ouvertes.fr/inserm-00903747

D. Blessborn, S. Romsing, A. Annerberg, D. Sundquist, A. Bjorkman et al., Development and validation of an automated solid-phase extraction and liquid chromatographic method for determination of lumefantrine in capillary blood on sampling paper, Journal of Pharmaceutical and Biomedical Analysis, vol.45, issue.2, pp.282-287, 2007.
DOI : 10.1016/j.jpba.2007.07.015

E. Hodel, B. Zanolari, T. Mercier, J. Biollaz, J. Keiser et al., A single LC???tandem mass spectrometry method for the simultaneous determination of 14 antimalarial drugs and their metabolites in human plasma, Journal of Chromatography B, vol.877, issue.10, pp.867-886, 2009.
DOI : 10.1016/j.jchromb.2009.02.006

R. Mcgready, S. Lee, J. Wiladphaingern, E. Ashley, M. Rijken et al., Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study, The Lancet Infectious Diseases, vol.12, issue.5, pp.388-396, 2011.
DOI : 10.1016/S1473-3099(11)70339-5

D. Sinclair, B. Zani, S. Donegan, P. Olliaro, and P. Garner, Artemisinin-based combination therapy for treating uncomplicated malaria, Cochrane Database Syst Rev, vol.3, p.7483, 2009.

J. Zwang, J. Ndiaye, A. Djimde, G. Dorsey, A. Martensson et al., Comparing changes in haematologic parameters occurring in patients included in randomized controlled trials of artesunate-amodiaquine vs single and combination treatments of uncomplicated falciparum in sub-Saharan Africa, Malaria Journal, vol.11, issue.1, p.25, 2012.
DOI : 10.1002/bdrb.20282

J. Kurtzhals, C. Reimert, E. Tette, S. Dunyo, K. Koram et al., Increased eosinophil activity in acute Plasmodium falciparum infection-association with cerebral malaria, Clinical and Experimental Immunology, vol.74, issue.2, pp.303-307, 1998.
DOI : 10.1016/0022-1759(93)90359-F

G. Adjei, J. Kurtzhals, O. Rodrigues, M. Alifrangis, L. Hoegberg et al., Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up, Malaria Journal, vol.7, issue.1, p.127, 2008.
DOI : 10.1186/1475-2875-7-127

G. Dorsey, S. Staedke, T. Clark, D. Njama-meya, B. Nzarubara et al., Combination Therapy for Uncomplicated Falciparum Malaria in Ugandan Children, JAMA, vol.297, issue.20, pp.2210-2219, 2007.
DOI : 10.1001/jama.297.20.2210

C. Maiteki-sebuguzi, P. Jagannathan, V. Yau, T. Clark, D. Njama-meya et al., Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children, Malaria Journal, vol.7, issue.1, p.106, 2008.
DOI : 10.1186/1475-2875-7-106

K. Dooley, C. Flexner, and A. Andrade, Drug Interactions Involving Combination Antiretroviral Therapy and Other Anti???Infective Agents: Repercussions for Resource???Limited Countries, The Journal of Infectious Diseases, vol.198, issue.7, pp.948-961, 2008.
DOI : 10.1086/591459
URL : http://jid.oxfordjournals.org/cgi/content/short/198/7/948

A. Gasasira, M. Kamya, J. Achan, T. Mebrahtu, J. Kalyango et al., High Risk of Neutropenia in HIV???Infected Children following Treatment with Artesunate plus Amodiaquine for Uncomplicated Malaria in Uganda, Clinical Infectious Diseases, vol.46, issue.7, pp.985-991, 2008.
DOI : 10.1086/529192

B. Faye, A. Offianan, J. Ndiaye, R. Tine, W. Toure et al., Efficacy and tolerability of artesunate-amodiaquine (Camoquin plus) versus artemether-lumefantrine (Coartem) against uncomplicated Plasmodium falciparum malaria: multisite trial in Senegal and Ivory Coast, Trop Med Int Health, vol.15, pp.608-613, 2010.
URL : https://hal.archives-ouvertes.fr/pasteur-00767126

J. Ndiaye, F. B. Gueye, A. Tine, R. Ndiaye, D. Tchania et al., Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial, Malaria Journal, vol.10, issue.1, p.237, 2011.
DOI : 10.1111/j.1365-3156.2008.02119.x

S. Fitoussi, C. Thang, E. Lesauvage, J. Barre, B. Charron et al., Bioavailability of a co-formulated combination of amodiaquine and artesunate under fed and fasted conditions. A randomised, open-label crossover study, Arzneimittelforschung, vol.59, pp.370-376, 2009.

S. Staedke, P. Jagannathan, A. Yeka, H. Bukirwa, K. Banek et al., Monitoring antimalarial safety and tolerability in clinical trials: A case study from Uganda, Malaria Journal, vol.7, issue.1, p.107, 2008.
DOI : 10.1186/1475-2875-7-107

J. Zwang, G. Dorsey, A. Djimde, C. Karema, A. Martensson et al., Clinical tolerability of artesunate-amodiaquine versus comparator treatments for uncomplicated falciparum malaria: an individual-patient analysis of eight randomized controlled trials in sub-Saharan Africa, Malaria Journal, vol.11, issue.1, p.260, 2012.
DOI : 10.1186/1475-2875-6-118

. Schramm, Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia, Malaria Journal, vol.12, issue.1, p.250, 2013.
DOI : 10.1186/1475-2875-11-260
URL : https://hal.archives-ouvertes.fr/inserm-00854378